CHESTERBROOK, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) ("Trevena" or the "Company"), a biopharmaceutical company focused on the development and commercialization of novel
OLINVYK demonstrated statistically significant reduced impact on neurocognitive functioning vs IV morphine on primary endpoint
CHESTERBROOK, Pa., June 14, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with c

Best Penny Stocks to Buy Next Week? 3 to Watch?

03:00pm, Sunday, 12'th Jun 2022 PennyStocks
Can these penny stocks make gains this coming week? The post Best Penny Stocks to Buy Next Week? 3 to Watch? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Can these penny stocks make gains this coming week? The post Best Penny Stocks to Buy Next Week?

Trevena to Participate at the JMP Securities Life Sciences Conference

11:00am, Friday, 10'th Jun 2022 GlobeNewswire Inc.
CHESTERBROOK, Pa., June 10, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with c

Hot Penny Stocks Under $1 To Watch In June

07:56pm, Thursday, 02'nd Jun 2022 PennyStocks
Penny stocks to watch under $1 right now The post Hot Penny Stocks Under $1 To Watch In June appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trevena to Present at the H.C. Wainwright Global Investment Conference

08:05pm, Wednesday, 18'th May 2022 GlobeNewswire Inc.
CHESTERBROOK, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with ce
CHESTERBROOK, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with cent
Trevena, Inc. (NASDAQ:TRVN ) Q1 2022 Earnings Conference Call May 11, 2022 8:00 AM ET Company Participants Barry Shin - Senior Vice President & Chief Financial Officer Carrie Bourdow - President & Chi

Trevena (TRVN) Reports Q1 Loss, Lags Revenue Estimates

12:15pm, Wednesday, 11'th May 2022 Zacks Investment Research
Trevena (TRVN) delivered earnings and revenue surprises of -11.11% and 96.94%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Trevena (TRVN) delivered earnings and revenue surprises of -11.11% and 96.94%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Reata Pharmaceuticals, Inc. (RETA) Reports Q1 Loss, Misses Revenue Estimates

11:55am, Tuesday, 10'th May 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) delivered earnings and revenue surprises of 10.18% and 52.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the s
Company to host a Conference Call & Webcast at 8:00 a.m. ET Company to host a Conference Call & Webcast at 8:00 a.m. ET
Trevena (TRVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE